SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis

References

• Vaessen-Verberne AAPH, van den Berg NJ, van Nierop JC, Brackel HJL, Gerrits GPJM, Hop WCJ, Duiverman EJ. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. Am J Respir Crit Care Med. 2010;182(10):1221–1227. doi:10.1164/rccm.201002-0193OC.
   PubMed Web of Science ®Google Scholar
• Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med. 2017;377(10):965–976. doi:10.1056/NEJMra1608969.
   PubMed Web of Science ®Google Scholar
• Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129(5):1229–1235. doi:10.1016/j.jaci.2012.01.039.
   PubMed Web of Science ®Google Scholar
• Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC.
   PubMed Web of Science ®Google Scholar
• Asthma GIf. Global Strategy for Ashtma Management and Prevention; 2021 [accessed May 6, 2021]. https://ginasthma.org/.
   Google Scholar
• Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: A systematic review and meta-analysis. JAMA. 2018;319(14):1485–1496. doi:10.1001/jama.2018.2769.
   PubMed Web of Science ®Google Scholar
• Neffen H, Fritscher C, Schacht FC, Levy G, Chiarella P, Soriano JB, Mechali D, AIRLA Survey Group. Asthma control in Latin America: the asthma insights and reality in Latin America (AIRLA) survey. Rev Panam Salud Publica. 2005;17(3):191–197. doi:10.1590/s1020-49892005000300007.
   PubMed Web of Science ®Google Scholar
• Paggiaro P, Barbaglia S, Centanni S, Croce D, Desideri E, Giustini S, Micheletto C, Musarra A, Scichilone N, Trama U, et al. Overcoming barriers to the effective management of severe asthma in Italy. J Asthma Allergy. 2021;14:481–491. doi:10.2147/JAA.S293380.
   PubMed Web of Science ®Google Scholar
• Florez-Tanus A, Parra D, Zakzuk J, Caraballo L, Alvis-Guzman N. Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis. World Allergy Organ J. 2018;11(1):26. doi:10.1186/s40413-018-0205-4.
   PubMed Web of Science ®Google Scholar
• Einarson TR, Bereza BG, Nielsen TA, Hemels ME. Utilities for asthma and COPD according to category of severity: a comprehensive literature review. J Med Econ. 2015;18(7):550–563. doi:10.3111/13696998.2015.1025793.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–1887. doi:10.1056/NEJMoa1715275.
   PubMed Web of Science ®Google Scholar
• Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet L-P, Naya IP, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20(9):1403–1418. doi:10.1185/030079904X2051.
   PubMed Web of Science ®Google Scholar
• Lloyd A, Price D, Brown R. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK. Prim Care Respir J. 2007;16(1):22–27. doi:10.3132/pcrj.2007.00002.
   PubMedGoogle Scholar
• (DANE) DNdE. Archivo nacional de datos; 2019. https://sitios.dane.gov.co/anda-index/.
   Google Scholar
• Beltrán J, González A, Moraes F, Alfonso Cristancho R, Di Boscio V, Soares C. Características clínicas, gravedad y control del asma en Colombia: un análisis post hoc del estudio ASLA (Asthma control in Latin America). Rev Colomb Neumol. 2020;31(2). Available from: https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/405 [last accessed 17 December 2021].
   Google Scholar
• Jacob C, Haas JS, Bechtel B, Kardos P, Braun S. Assessing asthma severity based on claims data: a systematic review. Eur J Health Econ. 2017;18(2):227–241. doi:10.1007/s10198-016-0769-2.
   PubMed Web of Science ®Google Scholar
• Ställberg B, Ekström T, Neij F, Olsson P, Skoogh B-E, Wennergren G, Löfdahl C-G. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. Respir Med. 2008;102(10):1360–1370. doi:10.1016/j.rmed.2008.06.017.
   PubMed Web of Science ®Google Scholar
• Price D, Wiren A, Kuna P. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy. 2007;62(10):1189–1198. doi:10.1111/j.1398-9995.2007.01466.x.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA. Cost effectiveness of pharmacological treatments for asthma: A systematic review. Pharmacoeconomics. 2018;36(10):1165–1200. doi:10.1007/s40273-018-0668-8.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez CE, Sossa-Briceno Mp, Nino G. Budesonide/formoterol as maintenance and reliever therapy compared to fixed-budesonide/formoterol plus albuterol reliever for pediatric asthma: A cost-utility analysis in Colombia. J Allergy Clin Immunol Pract. 2021;9(10):3816–3818.e2. doi:10.1016/j.jaip.2021.05.023.
   PubMed Web of Science ®Google Scholar
• Reddel HK, O’Byrne PM, FitzGerald JM, Barnes PJ, Zheng J, Ivanov S, Lamarca R, Puu M, Alagappan VKT, Bateman ED. Efficacy and safety of As-needed budesonide-formoterol in adolescents with mild asthma. J Allergy Clin Immunol Pract. 2021;9(8):3069–3077.e6. doi:10.1016/j.jaip.2021.04.016.
   PubMed Web of Science ®Google Scholar
• Hatter L, Bruce P, Braithwaite I, Holliday M, Fingleton J, Weatherall M, Beasley R. ICS-formoterol reliever versus ICS and short-acting β-agonist reliever in asthma: a systematic review and meta-analysis. ERJ Open Res. 2021;7(1):00701-2020. doi:10.1183/23120541.00701-2020.
   PubMedGoogle Scholar
• Nalin U, Stout S, Portnoy JM. Single inhaler maintenance and reliever therapy in pediatric asthma. Curr Opin Allergy Clin Immunol. 2019;19(2):111–117. doi:10.1097/ACI.0000000000000518.
   PubMed Web of Science ®Google Scholar